Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 14853

Dallas, TX 75231

Study Summary:

Currently, a clinical research study is under way to evaluate the safety and tolerability of an investigational drug for people living with Systemic Lupus Erythematosus-SLE (DV7-SLE-02) every day.

SLE is the most common type of lupus, which mainly strikes young women of African, Hispanic, and Asian descent. If you have SLE, you may be eligible to participate in this important clinical research study.

Qualified Participants Must:

• Be at least 18 years of age
• Have a confirmed diagnosis of Systemic Lupus Erythematosus

Qualified Participants May Receive:

Study-related health examinations at no cost and study-related medication and care at no cost. Other eligibility criteria will apply and insurance is not required. Compensation for time and travel up to $1,375.00. This is a phase 1 study requiring multiple injections, blood draws, assessments and visits to the site.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.